1. Home
  2. ARWR vs AVDX Comparison

ARWR vs AVDX Comparison

Compare ARWR & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • AVDX
  • Stock Information
  • Founded
  • ARWR 2003
  • AVDX 2000
  • Country
  • ARWR United States
  • AVDX United States
  • Employees
  • ARWR N/A
  • AVDX N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • AVDX EDP Services
  • Sector
  • ARWR Health Care
  • AVDX Technology
  • Exchange
  • ARWR Nasdaq
  • AVDX Nasdaq
  • Market Cap
  • ARWR 1.7B
  • AVDX 1.6B
  • IPO Year
  • ARWR 1993
  • AVDX 2021
  • Fundamental
  • Price
  • ARWR $11.24
  • AVDX $7.60
  • Analyst Decision
  • ARWR Buy
  • AVDX Hold
  • Analyst Count
  • ARWR 11
  • AVDX 15
  • Target Price
  • ARWR $41.44
  • AVDX $9.79
  • AVG Volume (30 Days)
  • ARWR 2.3M
  • AVDX 1.6M
  • Earning Date
  • ARWR 05-08-2025
  • AVDX 05-07-2025
  • Dividend Yield
  • ARWR N/A
  • AVDX N/A
  • EPS Growth
  • ARWR N/A
  • AVDX N/A
  • EPS
  • ARWR N/A
  • AVDX 0.04
  • Revenue
  • ARWR $2,500,000.00
  • AVDX $438,940,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • AVDX $6.34
  • Revenue Next Year
  • ARWR $64.24
  • AVDX $10.52
  • P/E Ratio
  • ARWR N/A
  • AVDX $192.31
  • Revenue Growth
  • ARWR N/A
  • AVDX 15.29
  • 52 Week Low
  • ARWR $9.57
  • AVDX $6.61
  • 52 Week High
  • ARWR $30.41
  • AVDX $12.93
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 38.40
  • AVDX 42.05
  • Support Level
  • ARWR $9.64
  • AVDX $7.40
  • Resistance Level
  • ARWR $12.93
  • AVDX $7.93
  • Average True Range (ATR)
  • ARWR 1.18
  • AVDX 0.43
  • MACD
  • ARWR 0.18
  • AVDX -0.01
  • Stochastic Oscillator
  • ARWR 43.21
  • AVDX 32.02

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About AVDX AvidXchange Holdings Inc.

AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.

Share on Social Networks: